🇺🇸 Intermitent Dosing in United States

Intermitent Dosing (Intermitent Dosing) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intermitent Dosing in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intermitent Dosing approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intermitent Dosing in United States?

Community Research Initiative of New England is the originator. The local marketing authorisation holder may differ — check the official source linked above.